Biogen Inc.
BIIB · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | July 29, 2026 | — | 2.46B | — | 3.13 | — |
| 2026 Q1 | April 29, 2026 | 2.48B | 2.29B | 2.15 | 2.95 | +6.00% |
| 2025 Q4 | February 6, 2026 | 2.28B | 2.20B | 1.99 | 1.60 | +8.53% |
| 2025 Q3 | October 30, 2025 | 2.45B | 2.34B | 4.81 | 3.89 | +1.18% |
| 2025 Q2 | July 31, 2025 | 2.65B | 2.33B | 5.47 | 3.93 | +1.07% |
| 2025 Q1 | May 1, 2025 | 2.43B | 2.23B | 3.02 | 3.27 | -0.12% |
| 2024 Q4 | February 12, 2025 | 2.45B | 2.41B | 3.44 | 3.42 | -4.28% |
| 2024 Q3 | October 30, 2024 | 2.47B | 2.43B | 4.08 | 3.77 | -1.25% |
| 2024 Q2 | August 1, 2024 | 2.35B | 2.39B | 5.28 | 4.00 | -1.17% |
| 2024 Q1 | April 24, 2024 | 2.29B | 2.31B | 3.67 | 3.45 | +4.56% |
| 2023 Q4 | February 13, 2024 | 2.39B | 2.47B | 2.95 | 3.16 | -7.39% |
| 2023 Q3 | November 8, 2023 | 2.53B | 2.39B | 4.36 | 3.99 | -5.67% |
| 2023 Q2 | July 25, 2023 | 2.46B | 2.37B | 4.02 | 3.77 | -2.42% |
| 2023 Q1 | April 25, 2023 | 2.46B | 2.34B | 3.40 | 3.25 | -3.62% |
| 2022 Q4 | February 15, 2023 | 2.54B | 2.45B | 4.05 | 3.51 | -3.49% |
| 2022 Q3 | October 25, 2022 | 2.51B | 2.47B | 4.77 | 4.13 | -0.39% |